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Abstract
ES-62 is the major secreted product of the parasitic ﬁlarial nematode Acanthocheilonema viteae
and has potent anti-inﬂammatory activities as a consequence of posttranslational decoration by
phosphorylcholine (PC). Previously, we showed that ES-62’s PC was attached to N-linked glycans,
and using fast atom bombardment mass spectrometry, we characterized the structure of the
glycans. However, it was unknown at this time which of ES-62’s four potential N-glycosylation sites
carries the PC-modiﬁed glycans. In the present study, we now employ more advanced analytical
tools—nano-ﬂow liquid chromatography with high-deﬁnition electrospray mass spectrometry—
to show that PC-modiﬁed glycans are found at all four potential N-glycosylation sites. Also, our
earlier studies showed that up to two PC groups were detected per glycan, and we are now able
to characterize N-glycans with up to ﬁve PC groups. The number per glycan varies in three of the
four glycosylation sites, and in addition, for the ﬁrst time, we have detected PC on the N-glycan
chitobiose core in addition to terminal GlcNAc. Nevertheless, the majority of PC is detected on
terminal GlcNAc, enabling it to interact with the cells and molecules of the immune system. Such
expression may explain the potent immunomodulatory effects of a molecule that is considered to
have signiﬁcant therapeutic potential in the treatment of certain human allergic and autoimmune
conditions.
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Introduction
ES-62 is the major secreted product of the parasitic rodent filarial
nematode Acanthocheilonema viteae (Harnett et al. 1989). Parasitic
worms as a group are known to secrete highly potent immunomod-
ulatory molecules (reviewed by Harnett 2014), and consistent with
this, comprehensive functional analysis of ES-62 has revealed it to
modulate or impair the activities of a number of cells of the immune
system (reviewed by Pineda et al. 2014). ES-62 achieves such effects
by direct interaction with cells via specific receptors like Toll-like
receptor 4 and subsequent subversion of associated cell signaling
pathways (Pineda et al. 2014). The net effect of ES-62 is thus conver-
sion of a pro-inflammatory to an anti-inflammatory immunological
phenotype. As a consequence of this, ES-62 has been tested in a
range of mouse models of allergic and autoimmune conditions and
was found to offer protection against the development of lung and
skin hypersensitivity (Melendez et al. 2007), arthritis (McInnes et al.
2003), systemic lupus erythematosus (SLE) (Rodgers et al. 2015)
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and the accelerated atherosclerosis associated with SLE (Aprahamian
et al. 2015). For this reason, ES-62 is considered to have significant
therapeutic potential against such conditions and toward this, novel
synthetic drug-like small molecule analogues (SMAs), which mirror
the parent molecules capabilities, have been successfully produced
(Al-Riyami et al. 2013).
The amino acid sequence of ES-62 is consistent with it being an
exopeptidase and indeed weak peptidase activity has been obtained
when employing artificial substrates (Harnett et al. 1999). However,
ES-62’s immunomodulatory properties are not due to such activ-
ity but rather to a posttranslational modification, the addition of
PC (reviewed by Pineda et al. 2014). By the use of the enzyme
N-glycosidase F and the inhibitor of initiation of N-type glycosy-
lation, tunicamycin, it was possible to show that ES-62’s PC was
attached via an N-linked glycans (reviewed by Harnett et al. 2010).
Further work employing inhibitors of intracellular trafficking and
oligosaccharide processing suggested that the substrate for PC addi-
tion was the 3-linked branch of Man5GlcNAc3 or Man3GlcNAc3
(Harnett et al. 2010). Consistent with this, subsequent fast atom
bombardment mass spectrometry analysis of ES-62’s N-linked gly-
cans suggested a structure in which PC is first transferred to the
antennary GlcNAc that is added by GlcNAc transferase I to the 3-
linked mannose of the tri-mannosyl core with additional PC groups
being added as further oligosaccharide processing results in other
antennary GlcNAc residues being added (Haslam et al. 1997).
In terms of the characterization of glycosylation in nematodes,
the majority of publications analyze released glycans from nema-
tode homogenates or excretory–secretory (ES) products. In addi-
tion, studies have utilized lectin affinity chromatography to purify
glycoproteins from Caenorhabditis elegans, which after proteolytic
digestion, were then either identified by Edman degradation protein
sequencing (Hirabayashi et al. 2002), or after enzymatic removal of
N-glycans by mass spectrometry based proteomics (Fan et al. 2005).
There have been very few site-specific glycoproteomic characteriza-
tions of individual nematode glycoproteins. However, Borloo et al.
(2013) did characterize N-glycosylation sites in the ES glycoproteins
of Cooperia oncophora. The amino acid sequence of ES-62 contains
four potential N-glycosylation sequons with an addition sequon
being present in the predicted signal peptide and therefore not present
on the mature glycoprotein (Harnett et al. 1999). In the present study,
we have employed LC-ES-MS/MS glycoproteomic methodologies to
further investigate the structure of ES-62’s PC-containing glycans
and also to determine the occupancy and degree of heterogeneity of
PC-containing glycans at the different glycosylation sites.
Results
Samples of the purified ES-62 were subjected to a panel of enzymatic
and chemical treatments, designed to characterize the occupancy and
glycoforms present at each putative N-glycosylation site. Discounting
the 19 residue predicted signal peptide, over 96% of the mature
protein was successfully mapped across the tryptic, chymotryptic and
Glu-C proteolytic digests, including all four of the N-glycosylation
consensus sequences identified with searches targeting previously
identified ES-62 glycans (Haslam et al. 1997) (Supplementary
Figure 1, Supplementary Table S1).
Site occupancy
An indication of N-glycosylation site occupancy was achieved by
taking aliquots of the tryptic, chymotryptic and Glu-C digested ES-
62 and treating each with PNGase-F to remove N-linked glycans and
deamidate occupied asparagine residues prior to subsequent analysis
by LC-MSe. In a MSe experiment data are acquired via alternating
between low- and high-collision energy conditions (Silva et al. 2005).
However, it should be noted that spontaneous chemical deamidation
is also possible (Palmisano et al. 2012; Stephenson and Clarke, 1989).
Extracted ion chromatograms (XICs) were then produced from the
resultant data, comparing the integrated peak areas for the deami-
dated (occupied) glycopeptides and their corresponding amidated
(non-occupied) versions (Supplementary Figures 2–5). These data
demonstrate 100% site occupancy at N254 and N344, with 91%
at N213 and 45% at N400.
PC detection
The detection of putative PC-modified glycopeptides was enabled by
exploiting both the marker ions of choline (m/z 104.1) and PC (m/z
184.1) (Figure 1), an approach published by Timm et al. (2015).
TheMSe channel (a non-discriminatorymethod of fragmentation)
of each ES-62 digest mass spectral analysis was interrogated for
the presence of these marker ions, with the resultant XICs shown
in Figure 2. Within each of the digests, there appeared to be a
significant number of high-intensity marker ion signals denoting the
Fig. 1. Characteristic fragment ion structures of choline (m/z 104.1) and PC (m/z 184.1) that were utilized to assist PC-containing glycopeptide identiﬁcation
(Timm et al. 2015).
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Fig. 2. XICs searching for evidence of choline (m/z 104.1) and PC (m/z 184.1) marker ions in the MS/MS (MSe) analyses of ES-62 digests. (A) Reduced,
carbamidomethylated Glu-C digest; (B) reduced, carbamidomethylated chymotrypsin digest; (C) reduced, carbamidomethylated trypsin digest.
Fig. 3. Deconvoluted MS/MS (MSe) spectrum of the m/z 5989.53 Asn 213 glycopeptide molecular ion, observed at a retention time of 55.8 min in the reduced,
carbamidomethylated trypsin digest of ES-62. Focus is on the high-mass region, showing the sequential loss of glycan residues from the intact glycopeptide.
labile-fragmentation of the PC groups from their respective glycans.
This proved to be a highly effective strategy and allowed the location
and characterization of PC-containing glycopeptides, generating a
wealth of data on the glycoforms present at each glycosylation site.
An example of the data quality generated from the fragmentation
of PC-modified glycopeptides is shown in Figures 3–5. This selection
of data shows the fragmentation of one of the glycopeptides observed
at a retention time of 55.8 min in the analysis of the trypsin digest
of ES-62. Figure 3 shows the high-mass region of the MSe spectrum,
illustrating the sequential loss of PC and glycan residues from the
molecular ion at m/z 5988.61. The PC moieties cleave away from the
remaining molecule in alternating fashion together with the GlcNAc
residues that carry them. In this instance a total of four PC-GlcNAc
antennal pairs are removed (together with the core fucose), before
the loss of the core mannose residues. Interestingly at this point,
a final PC-GlcNAc pair is lost from the core—demonstrating the
modification of the distal core GlcNAc, followed by the final proxi-
mal GlcNAc to leave the exposed carbamidomethyl-modified tryptic
glycopeptide 201–231 atm/z 3313.49 (Figure 3). A key fragment ion
series is also seen at m/z 3313.49, 3516.49, 3719.49 and 3885.69
again indicating the presence of PC modification of the distal core
GlcNAc.
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Fig. 4. Deconvoluted MS/MS (MSe) spectrum of the m/z 5989.53 Asn 213 glycopeptide molecular ion, observed at a retention time of 55.8 min in the reduced,
carbamidomethylated trypsin digest of ES-62. Focus is on the low-mass region, showing the fragmented glycan structures.
Fig. 5. Deconvoluted MS/MS (MSe) spectrum of the m/z 5989.53 Asn 213 glycopeptide molecular ion, observed at a retention time of 55.8 min in the reduced,
carbamidomethylated trypsin digest of ES-62. Focus is on the low-mass region, showing the peptide fragment ions.
The low-mass region of the same spectrum provides further
evidence for the structure of the PC-glycan, with a series of peaks
corresponding to PC-containing fragments. This region is dominated
by the intense PC and PC-GlcNAc signals at m/z 184.07 and 369.15,
respectively, together with additional PC-GlcNAc containing frag-
ment ions (Figure 4). No fragment ions at m/z 328 (PC-Man) or m/z
312 (PC-Fuc) could be observed again providing evidence that PC is
only present on GlcNAc residues. It is unusual to observe such an
abundance of fragmented glycan data in these analyses across the
entire mass range of the spectra, leading to the notion that the PC
groups are helping to retain charge and assist in the assignment of
the spectra.
The final view of the spectrum (Figure 5) is again the low-
mass region, this time magnified to show the confirmation of the
peptide sequence, via b and y” peptide fragment ions, also present
with the abundant PC-glycan fragment ions. A good proportion
of the C-terminus of the glycopeptide is assignable, with a series
of clear y” ions apparent before the signals diminish close to the
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Table I. Summary of the glycan structures observed at each con-
sensus site within the ES-62 molecule. The proposed structures
of the PC containing N-glycans have not been fully deﬁned, for
example in terms of branching pattern for triantennary structures.
Structural data from previous characterization of ES-62 was taken
into account (Haslam et al. 1997).
consensus sequence asparagine at residue 213. Additional assigned
deconvoluted spectra, which are fully consistent with the above
glycan structural features, are displayed in Supplementary Figures
10–12 .
A similar experimental strategy was utilized to characterize all
of the N-glycosylation sites. Tables 1 and 2 summarize the proposed
individual glycoforms observed at each of the four consensus sites
present in the mature protein, using the backbones of the structures
previously defined to inform the assignment of fucose, mannose and
GlcNAc. The sites are modified by a mixture of bi-, tri- and tetra-
antennary truncated glycans, with the Asn400 site additionally mod-
ified by high-mannose-type glycans, as previously reported (Haslam
et al. 1997). However, while prior analyses have established the
potential presence of a single PC on the multiantennary complex
structures, these data clearly demonstrate the extent to which this
modification is present, with up to five additions on the tetra-
antennary glycans.
As a consequence of the quality of the PC-glycopeptide data
described above we hypothesize that the presence of the PC residues
has a beneficial effect on the fragmentation spectra. To investigate
this an aliquot of the digested samples was treated with hydrofluoric
acid (HF) in order to break the phosphodiester bonds and remove
the PC moieties from the glycans. These samples were then once
more analyzed by LC-MS and the data quality of the glycopeptide
fragmentation compared to that of the non-treated samples. Partial
removal of the PC residues was achieved (Supplementary Figures 6–
9), with a commensurate reduction in the quality of the MS and
MSe data, rendering assignment of the fragmentation spectra much
more challenging. This provides some supporting evidence that the
quality of the fragment ion data observed in the MS/MS spectra of
the glycopeptides in this study is linked to the presence of the PC-
moieties.However, from the data presented it cannot be ruled out that
the HF treatment has caused additional degradation of the peptide
backbone.
From an analytical perspective we observed that the presence of
the PC-functional group on N-glycopeptides greatly enhanced their
sensitivity of detection by ES-MS. We presume this is due to the
additional permanent positive charge of the choline in the PC group.
Therefore, addition of PC groups onto other glycopeptides could
enhance their detection and characterization.
Discussion
Recently, there has been much interest in developing parasitic worm-
derived molecules as therapeutics for the treatment of a range of
human ailments associated with aberrant inflammatory responses
(reviewed by Harnett and Harnett 2017). ES-62 is generally con-
sidered to be in the forefront of this development and so there is a
need to learn as much as possible about its biology. Of particular
relevance is its PC moiety as this appears to be essentially responsible
for its anti-inflammatory activities (reviewed by Pineda et al. 2014)
and constitutes the starting point for an SMAdrug discovery program
(Al-Riyami et al. 2013). In this latest study focusing on ES-62, we
have undertaken, to our knowledge, the most detailed glycopro-
teomic characterization of a nematode glycoprotein to date and in
the process have demonstrated that all four potentialN-glycosylation
sites on the mature glycoprotein are occupied by PC-containing N-
glycans.
Our original studies on the structure of ES-62’s PC-glycan sug-
gested that PC was transferred to antennary GlcNAc residues, during
the process of the latter being added to the glycan during oligosac-
charide processing (reviewed by Harnett, Rzepecka and Houston
(Harnett et al. 2010)). We were subsequently able to confirm the
existence of the same structures in other filarial nematode species
including the medically important human pathogen that causes river
blindness, Onchocerca volvulus (Haslam et al. 1999). Furthermore,
around the same time PC was found attached to GlcNAc residues
on nematode glycosphingolipids (Lochnit et al. 1998). Subsequently
identical PC-sugar structures and in some cases additional PC-N-
glycan structures have been found in a number of nematode species
(reviewed by Hokke and van Diepen 2017) including the free-living
C. elegans (reviewed by Cipollo et al. 2004; Haslam et al. 2002). In
our original work on the PC-N-glycans of filarial nematode species
(Haslam et al. 1999; Haslam et al. 1997), we presented evidence for
the existence of up to two PC moieties per glycan. However, in this
new study it is clear that ES-62 N-glycans may contain up to five PC
groups. FAB-MS- and MALDI-MS-based structural characterization
of released PC-containing N-glycans is very challenging due to the
zwitterionic nature of the PC functional group and potential difficulty
in releasing heavily PC-substituted N-glycans with enzymes such as
peptide N-glycosidase F (PNGase F) and PNGase A: this could be
especially an issue for PC-modified cores. However, in this study ES-
MS-based analysis of PC containingN-glycopeptides is better able to
handle the multiple potential charge states, thus increasing the sen-
sitivity of detection of the higher PC substituted N-glycans. Four of
the PC groups are proposed to be on antennary GlcNAc residues with
the fifth on the distal core GlcNAc. The latter substitution was not
detected in our earlier work but has previously been described with
respect toC. elegans (Cipollo et al. 2005), although the indicationwas
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that PC could be added to both distal and proximal core GlcNAc in
the N-glycans of this species.
The identity of the enzyme that transfers PC to carbohydrates in
nematodes is unknown, but we have previously speculated (Harnett
et al. 2010) on whether the same or different transferases might
deliver PC to GlcNAc on both N-glycans and glycosphingolipids.
Support in favor of the former is perhaps that glycosyltransferases
have been reported to target both structures in vitro (reviewed by
Paulson and Colley 1989) and also that the acceptor for PC is
the same for both classes of molecule, the C-6 position of GlcNAc
(Gerdt et al. 1999; Haslam et al. 2002). If the one-PC transferase
model is indeed the case, then the same enzyme should also transfer
PC to core GlcNAc in N-glycans, and hence it would appear that
this sugar is simply the structure required to act as a PC acceptor.
However, the same glycosyltransferase is generally not employed for
modifying core and antenna sugars, and the fact that we do not
observe any PCmodification of the core GlcNAc residues of the high-
mannose glycans observed at the Asn400 site would seem to indicate
a degree of structural preference for the PC transferase. Furthermore,
PC has been found attached to terminal N-acetylgalactosamine in
the porcine nematode Trichuris suis (Wilson and Paschinger 2016),
indicating that if only one enzyme exists, it might be capable of
transferring PC to more than one sugar. In addition, in that study,
although N-glycans with terminal GlcNAc were present, PC was not
found attached to terminal GlcNAc but was found attached to sub-
terminal GlcNAc, raising the possibility that T. suis may perhaps
possess a different PC transferase to that found in those species
that transfer to terminal GlcNAc. Vanbeselaere et al. (2018) also
recently described an unusual PC-substituted glycosaminoglycan-like
O-glycan from the parasitic nematodeOesophagostomum dentatum
in which PC groups were determined on both HexNAc and galactose
residues.Overall, therefore, the question as to howmany different PC
transferases nematodes contain remains to be answered, and it may
be that the answer is different for individual species.
Our previous work in characterizing ES-62’s N-glycans also
revealed the existence of other types of structure in particular high-
mannose glycans and also glycans fully trimmed to the tri-mannosyl
core with or without core fucose (Haslam et al. 1997). This raised
the question as to how many of ES-62’s potential N-glycosylation
sites actually contain PC-glycans, but the answer from the present
glycoproteomics analysis of ES-62 indicates it is all four. As most
of the PC, being attached to terminal GlcNAc, at the end of gly-
can chains, this raises the possibility that ES-62 as a tetrameric
molecule of molecular mass ∼240 kDa presents a substantial PC
“coat” to the external environment, and such PC will have ample
opportunity to interact with the molecules and cells of the immune
system. Such molecules include antibodies and C-reactive protein.
Antibodies in theory could remove ES-62 from the circulation but
our previous studies in the model jird system suggest that this only
happens in the early stages of antibody production and not during
a chronic infection, a finding that may reflect a reduction in the
size of immune complexes as the antibody response to ES-62 moves
from IgM to IgG (smaller immune complexes tend to persist longer)
(Harnett et al. 1990). In any case, by presenting so many PC groups to
the external environment, it is possible that not all ES-62 PC groups
are bound by antibodies such that the potential for direct interac-
tion with receptors on immune system cells remains. Nevertheless,
antibodies may actually enhance uptake of ES-62 by Fc receptor-
expressing immune system cells, and it is possible that under such
circumstances the molecule may remain functional. Regarding C-
reactive protein, studies employing human serum reveal that this
is in fact the major protein bound by ES-62 with extremely large
complexes forming. Such interaction with C-reactive protein is of
high affinity and results in blockage of the molecule’s ability to
activate complement (Ahmed et al. 2016). Once again, the large
number of PC groups presented by ES-62 will be likely to contribute
to what is a very effective inhibitory effect. In addition, it should
facilitate multiple engagements with surface receptors of immune
system cells, which may help explain its potent ability to modulate
their activities (reviewed by Pineda et al. 2014). Based on our site-
specific glycoproteomic analysis, any one ES-62 tetramer (the form
in which the molecule is secreted) can contain up to 72 PC groups,
the majority of which, being present on antenna GlcNAc, will point
into space. This means that the PC on ES-62 has significant potential
to interact with appropriate receptors on cells and molecules of the
immune system and this may explain its potent immunomodulatory
effects.
Materials and methods
ES-62 preparation
Highly purified ES-62 was prepared from spent culture medium of
adult mixed-sex A. viteae by ultrafiltration as described previously
(Wilson et al. 2003).
Sample Preparation. Aliquots of the purified ES-62 (∼250 μg in
100 μL phosphate-buffered saline) was made up to 253 μL with
addition of 153 μL of 50 mM ammonium bicarbonate (ambic) buffer,
pH 8.4.
Protein Denaturation. A total of 20 μL of a 0.1%(w/v) solution of
RapiGestTM SF Surfactant (Waters, UK) was added to the sample.
The sample was incubated at 60◦C for 15 min.
Reduction and Alkylation. Reduction of thiol bridges and free thiols
was carried out by addition of 5 μL of a 20 mg/mL solution of
dithiothreitol (DTT) in 50 mM ambic buffer, pH 4.8, followed by
incubation at 60◦C for 60 min. Alkylation of exposed residues
was carried out by addition of 12 μL of a 20 mg/mL solution
of iodoacetamide in 50 mM ambic buffer, pH 8.4, followed by
incubation at ambient temperature for 30min in the dark.Quenching
of excess alkylation agent was performed by the addition of 10 μL of a
20 mg/mL solution of DTT in 50 mM ambic buffer, pH 8.4, followed
by incubation at ambient temperature for 10 min. The sample was
split into three identical aliquots of 100 μL each for proteolytic
digestion.
Chymotryptic Digest. A total of 100 μL of the reduced and alkylated
ES-62 sample was digested by adding 10 μL of a 1 mg/mL solution of
chymotrypsin in 50mMambic buffer, pH 8.4, followed by incubation
at 37◦C for 18 h.
Endoproteinase (Glu-C) Digest. A total of 100 μL of the reduced and
alkylated ES-62 sample was digested by adding 10 μL of a 1 mg/mL
solution of Glu-C in 50 mM ambic buffer, pH 8.4, followed by
incubation at 37◦C for 18 h.
Tryptic Digest. A total of 100 μL of the reduced and alkylated ES-
62 sample was digested by adding 10 μL of a 1 mg/mL solution of
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trypsin in 50 mM ambic buffer, pH 8.4, followed by incubation at
37◦C for 18 h.
RapiGestTM SF Surfactant Precipitation. Acid-labile surfactant pre-
cipitation was carried out by the addition of 0.5 μL of trifluoroacetic
acid to each of the three digested samples. Each sample was incubated
at 37◦C for 45 min, followed by centrifugation at 150,000 × g
for 15 min. The supernatant from each sample was recovered and
transferred to fresh tubes.
PNGase F Digestion. An aliquot of each digested sample (correspond-
ing to ∼25 μg of digested material) was taken and lyophilized. Each
freeze-dried digest sample was resuspended in 25 uL of 50 mM ambic
buffer, pH 8.4. A total of 2 U of PNGase F was added and incubated
for 24 h (with an additional 2 U aliquot of PNGase F added after
6 h).
HF Cleavage of Phosphodiester Bonds. An aliquot of each digested
sample (corresponding to ∼25 μg of digested material) was
lyophilized. Each freeze-dried digest sample was resuspended in
50 uL of 48% HF and incubated on ice for 20 h. The reaction was
terminated by gentle drying under nitrogen, followed by resuspension
in UHQ H2O and lyophilization.
Nano-LC MS and MS/MS Analysis of (glyco)peptides. Sample digests,
resuspended in 0.1% (v/v) formic acid, were analyzed by on-line
nano-flow reverse-phase high-performance liquid chromatography
with online electrospray-mass spectrometric analysis (nano-RP-
HPLC-ES-MS) with MS/MS (MSe) using a Waters SYNAPT G2-S
high-definition mass spectrometer, coupled to a Waters ACQUITY
UPLC M-Class System (Waters UK, Elstree). Separations were
achieved by means of a C18 trapping column (M-Class Symmetry
C18 Trap, 100 Å, 5 μm, 180 μm × 20 mm, 2G) connected in-
line with a 75 μm C18 reverse-phase analytical column (M-Class
Peptide BEH C18, 130 Å, 1.7 μm, 75 μm × 150 mm) eluted over
90 min with a gradient of acetonitrile in 0.1% formic acid at a
flow rate of 300 nL/min. Column temperatures were maintained
at 50◦C, and data were recorded in MSe “Resolution” positive
ion mode, with scan times set to 0.5 s in both the high-energy
and low-energy modes of operation. The instrument was pre-
calibrated using 10–100 fmol/μL of [Glu1]-fibrinopeptide B/5% (v/v)
acetic acid (1:3, v/v) and calibrated during analysis by means of
a lockmass system using [Glu1]-Fibrinopeptide B 785.84262+ ion.
The collision gas utilized was argon with collision energy ramp
of 20–45 eV. Data acquisition was performed using MassLynx
(Waters UK, Elstree) software and analyzed by means of MassLynx,
BiopharmaLynx and ProteinLynx Global Server (PLGS) version 3.0.2
(Waters UK, Elstree).
Supplementary data
Supplementary Data is available at Glycobiology online.
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Abbreviations
CDNSHP completely de-sulfated,N-sulfated heparin
ECM extracellular matrix
GAGs, glycosaminoglycans
Gal, β-D-galactose
GalNAc N-acetyl-D-galactosamine
GlcA β-D-glucuronic acid
GlcNAc N-acetyl-α-D-glucosamine
GST glutathione S-transferase
NAHP non-anticoagulant heparin
HN heparosan
HN6S heparosan 6S
HP heparin
HS heparan sulfate
NSHN N-deacetylated,N-sulfoheparosan;
NSHN2S N-deacetylated,N-sulfated C5-epimerase treated
2-O-sulfated heparosan
NSHN6S N-deacetylated,N-sulfated, 6-O-sulfated heparosan
IdoA α-L-iduronic acid
IPTG isopropyl-1-thio-β-D-galactopyranoside
PGs proteoglycans
UA uronic acid
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